CORDIS · A4L_ACTIONS
Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe
- Код
A4L_ACTIONS- Програма
- H2020
- Процедура
SC1-HCO-03-2020- Статус
- CLOSED
- Период
- 01.05.2021 – 30.04.2024
Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис
Участници
| Организации | Роля | Държава | Безвъзмездна помощ |
|---|---|---|---|
| Masarykova univerzita | координатор | CZ | 561 476 € |
| LATVIJAS ORGANISKAS SINTEZES INSTITUTS | участник | LV | 155 912 € |
| SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET | участник | HR | 155 788 € |
| BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA | участник | SK | 149 538 € |
| SEMMELWEIS EGYETEM | участник | HU | 148 169 € |
| UNIWERSYTET MEDYCZNY W LODZI | участник | PL | 146 919 € |
| TARTU ULIKOOL | участник | EE | 140 938 € |
| VILNIAUS UNIVERSITETAS | участник | LT | 130 788 € |
| FAKULTNI NEMOCNICE U SV ANNY V BRNE | участник | CZ | 124 294 € |
| UNIVERZA V LJUBLJANI | участник | SI | 114 662 € |
| UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTI | участник | RO | 97 038 € |
| МЕДИЦИНСКИ УНИВЕРСИТЕТ | участник | BG | 74 412 € |
Описание
The gap in Research and Innovation (R&I) performance, which persists despite considerable investments from the European Structural and Investment Funds (ESIF) in the lower-performing regions of the EU, is an issue with major socio-economic and political consequences. In Health R&I the gap has a profound impact on distribution of funding from the EU Framework Programmes as well as on hindering the EU-wide impact of R&I on health and quality of life. With A4L_ACTIONS, we aim to address roots of this situation in the lower-performing Central and Eastern Europe (CEE) by improving culture, governance, recognition and innovation potential of the health research-performing institutions. Our goal is to increase their attractiveness for collaborations with advanced Europe and create spill-over effects in the whole region. As the Alliance4Life, we are an established network of progressive health research institutions in CEE and a source of successfully piloted good practice. By building upon our results and impact achieved so far, we will convert our recommendations and strategies into actions as follows:- Culture fostering excellence: piloting peer-evaluation and assessment of institutional practice as a strategic management tool, professionalizing research administration;- Recognition and trust towards CEE: attracting advanced partners to identified pockets of excellence, supporting scientific ideas originating in CEE, initiating new international projects and collaborations with industry;- Career policy nurturing talent: training and networking next generation of leaders, upgrading institutional career systems;- Impact on innovation: raising the competences of Technology Transfer specialists, creating industry relations platform linking academia and industry;- Spill-over effects: sharing, inspiring, communicating with stakeholders and policy makers; using the established networks to gain advice, new collaborations and EU-wide impact.
Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис · Лиценз: © European Union, CC BY 4.0 (Commission reuse policy).